Massachusetts-based NinePoint Medical Imaging closed a $34 million Series B funding round, the company announced today.
NinePoint plans to use the funds to support ongoing U.S. commercial efforts for its NvisionVLE system, which provides high-res, endoscopicimaging of organs and tissues. The system can provide cross-sectional, volumetric views of organs, including tissues below the surface, the company said.